A comparative study of serum growth hormone and plasma cortisol levels in stimulation tests with insulin and propranolol-glucagon
- PMID: 1173985
- DOI: 10.1530/acta.0.0800070
A comparative study of serum growth hormone and plasma cortisol levels in stimulation tests with insulin and propranolol-glucagon
Abstract
Insulin and propranolol-glucagon stimulation tests were carried out on 28 children and 5 adolescents and the results of their growth hormone and plasma cortisol estimations were compared. Twenty-nine subjects with normal growth hormone reserves showed a mean maximum rise of 17.4 muU/ml of serum growth hormone in the insulin test whereas the intramuscular injection of glucagon after oral premedication with propranolol produced a rise of 38.5 muU/ml. Five subjects with normal growth hormone reserves showed a reduced hormone output in the insulin stimulation tests but normal response in the propranolol-glucagon stimulation tests. Only one subject showed a poor response in the propranolol-glucagon but normal response in the insulin stimulation test. In 30 subjects with normal adrenocortical function the mean maximum increase of plasma cortisol was 15.6 muU/ml in the insulin - and 14.9 muU/ml in the propranolol-glucagon stimulation tests, respectively. Both methods are suitable for studying the pituitary-adrenocortical interrelationships. The mechanism of the release of glucagon-induced growth hormone is not clear but the fall in blood glucose does not seem to play a major role in the process. A stress-like mechanism is equally unlikely because vegetative symptoms occurred only i a small number of subjects after intramuscular glucagon administration. It is possible that glucagon possesses a releasing-like mechanism which operates in the pituitary itself.
Similar articles
-
Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.Horm Metab Res. 1977 Jan;9(1):17-21. doi: 10.1055/s-0028-1093576. Horm Metab Res. 1977. PMID: 403115
-
The effect of glucose on the growth hormone response to glucagon and propranolol-glucagon in normal subjects.Metabolism. 1975 Sep;24(9):1009-14. doi: 10.1016/0026-0495(75)90093-1. Metabolism. 1975. PMID: 1152673
-
Growth hormone responses to propranolol-glucagon stimulation: a comparison with other tests of growth hormone reserve.J Clin Endocrinol Metab. 1973 Jul;37(1):85-92. doi: 10.1210/jcem-37-1-85. J Clin Endocrinol Metab. 1973. PMID: 4715297 No abstract available.
-
Growth hormone and cortisol secretion after propranolol--glucagon testing in the adult.Metabolism. 1974 Sep;23(9):853-62. doi: 10.1016/0026-0495(74)90119-x. Metabolism. 1974. PMID: 4852189 No abstract available.
-
Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.J Clin Invest. 1979 Jul;64(1):62-71. doi: 10.1172/JCI109464. J Clin Invest. 1979. PMID: 36413 Free PMC article.
Cited by
-
Pre- and postoperative evaluation of hypothalamo- pituitary function in children with craniopharyngiomas.Acta Neurochir (Wien). 1979;45(3-4):287-99. doi: 10.1007/BF01769142. Acta Neurochir (Wien). 1979. PMID: 425859
-
Metabolic and hormonal responses to exhaustive supramaximal running with and without beta-adrenergic blockade.Eur J Appl Physiol Occup Physiol. 1984;52(2):214-8. doi: 10.1007/BF00433395. Eur J Appl Physiol Occup Physiol. 1984. PMID: 6143664 Clinical Trial.
-
Thyroid function in children with growth hormone deficiency, either idiopathic or caused by diseases of the central nervous system.Eur J Pediatr. 1978 Jul 19;128(4):273-81. doi: 10.1007/BF00445612. Eur J Pediatr. 1978. PMID: 97084
-
[Catecholamines, GH, cortisol, glucagon, insulin, and sex hormones in exercise and beta 1-blockade (author's transl)].Klin Wochenschr. 1982 May 17;60(10):505-12. doi: 10.1007/BF01756096. Klin Wochenschr. 1982. PMID: 6124653 Clinical Trial. German.
-
Influence of xamoterol, a partial beta 1-selective agonist, on physical performance capacity and cardiocirculatory, metabolic and hormonal parameters.Eur J Clin Pharmacol. 1988;34(3):255-62. doi: 10.1007/BF00540952. Eur J Clin Pharmacol. 1988. PMID: 2899509 Clinical Trial.